Compare KALV & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | BZH |
|---|---|---|
| Founded | N/A | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.7M | 672.0M |
| IPO Year | 2014 | 1995 |
| Metric | KALV | BZH |
|---|---|---|
| Price | $15.75 | $20.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $30.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 721.4K | 355.7K |
| Earning Date | 03-25-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $50,000,000.00 | ★ $2,087,739,000.00 |
| Revenue This Year | N/A | $4.36 |
| Revenue Next Year | N/A | $10.79 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 495.66 | N/A |
| 52 Week Low | $9.83 | $17.37 |
| 52 Week High | $19.00 | $28.33 |
| Indicator | KALV | BZH |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 24.38 |
| Support Level | $14.59 | $19.90 |
| Resistance Level | $16.49 | $24.10 |
| Average True Range (ATR) | 0.98 | 0.72 |
| MACD | -0.06 | -0.42 |
| Stochastic Oscillator | 13.35 | 0.00 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.